HEADER TRANSFERASE/TRANSFERASE INHIBITOR 28-MAR-12 4EEV TITLE CRYSTAL STRUCTURE OF C-MET IN COMPLEX WITH LY2801653 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPATOCYTE GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN (UNP RESIDUES 1038-1346); COMPND 5 SYNONYM: HGF RECEPTOR, HGF/SF RECEPTOR, PROTO-ONCOGENE C-MET, SCATTER COMPND 6 FACTOR RECEPTOR, SF RECEPTOR, TYROSINE-PROTEIN KINASE MET; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MET; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PROTEIN TYROSINE KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Y.WANG,S.L.STOUT REVDAT 3 28-FEB-24 4EEV 1 REMARK SEQADV REVDAT 2 04-SEP-13 4EEV 1 JRNL REVDAT 1 10-APR-13 4EEV 0 JRNL AUTH S.B.YAN,V.L.PEEK,R.AJAMIE,S.G.BUCHANAN,J.R.GRAFF, JRNL AUTH 2 S.A.HEIDLER,Y.H.HUI,K.L.HUSS,B.W.KONICEK,J.R.MANRO,C.SHIH, JRNL AUTH 3 J.A.STEWART,T.R.STEWART,S.L.STOUT,M.T.UHLIK,S.L.UM,Y.WANG, JRNL AUTH 4 W.WU,L.YAN,W.J.YANG,B.ZHONG,R.A.WALGREN JRNL TITL LY2801653 IS AN ORALLY BIOAVAILABLE MULTI-KINASE INHIBITOR JRNL TITL 2 WITH POTENT ACTIVITY AGAINST MET, MST1R, AND OTHER JRNL TITL 3 ONCOPROTEINS, AND DISPLAYS ANTI-TUMOR ACTIVITIES IN MOUSE JRNL TITL 4 XENOGRAFT MODELS. JRNL REF INVEST NEW DRUGS V. 31 833 2013 JRNL REFN ISSN 0167-6997 JRNL PMID 23275061 JRNL DOI 10.1007/S10637-012-9912-9 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.94 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 27552 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.190 REMARK 3 R VALUE (WORKING SET) : 0.189 REMARK 3 FREE R VALUE : 0.215 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1388 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.85 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1924 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.85 REMARK 3 BIN R VALUE (WORKING SET) : 0.2340 REMARK 3 BIN FREE R VALUE SET COUNT : 97 REMARK 3 BIN FREE R VALUE : 0.2810 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2206 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 41 REMARK 3 SOLVENT ATOMS : 125 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 28.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.26 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.75000 REMARK 3 B22 (A**2) : 0.48000 REMARK 3 B33 (A**2) : -2.23000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.132 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.120 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.086 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.757 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.961 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.955 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2346 ; 0.014 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 1555 ; 0.006 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3198 ; 1.588 ; 1.986 REMARK 3 BOND ANGLES OTHERS (DEGREES): 3817 ; 0.973 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 293 ; 5.193 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 89 ;31.668 ;23.596 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 394 ;12.696 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 10 ;15.998 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 361 ; 0.099 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2644 ; 0.007 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 463 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 4EEV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-APR-12. REMARK 100 THE DEPOSITION ID IS D_1000071529. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 31-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX225HE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA 2.7.2 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 45914 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.511 REMARK 200 RESOLUTION RANGE LOW (A) : 19.940 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 9.400 REMARK 200 R MERGE (I) : 0.08600 REMARK 200 R SYM (I) : 0.08600 REMARK 200 FOR THE DATA SET : 10.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.51 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.2 REMARK 200 DATA REDUNDANCY IN SHELL : 8.50 REMARK 200 R MERGE FOR SHELL (I) : 0.06000 REMARK 200 R SYM FOR SHELL (I) : 6.01700 REMARK 200 FOR SHELL : 0.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.01 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 16% PEG 10.000, 0.1 M HEPES, AND 5% REMARK 280 ETHYLENE GLYCOL, PH 7.0, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 20.25400 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 55.81550 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 31.94300 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 55.81550 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 20.25400 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 31.94300 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1030 REMARK 465 HIS A 1031 REMARK 465 HIS A 1032 REMARK 465 HIS A 1033 REMARK 465 HIS A 1034 REMARK 465 HIS A 1035 REMARK 465 HIS A 1036 REMARK 465 MET A 1037 REMARK 465 GLY A 1038 REMARK 465 ASP A 1039 REMARK 465 SER A 1040 REMARK 465 ASP A 1041 REMARK 465 ILE A 1042 REMARK 465 SER A 1043 REMARK 465 SER A 1044 REMARK 465 LEU A 1225 REMARK 465 ALA A 1226 REMARK 465 ARG A 1227 REMARK 465 ASP A 1228 REMARK 465 MET A 1229 REMARK 465 TYR A 1230 REMARK 465 ASP A 1231 REMARK 465 LYS A 1232 REMARK 465 GLU A 1233 REMARK 465 TYR A 1234 REMARK 465 TYR A 1235 REMARK 465 SER A 1236 REMARK 465 VAL A 1237 REMARK 465 HIS A 1238 REMARK 465 ASN A 1239 REMARK 465 LYS A 1240 REMARK 465 THR A 1241 REMARK 465 GLY A 1242 REMARK 465 ALA A 1243 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN A1049 CG OD1 ND2 REMARK 470 ARG A1086 CD NE CZ NH1 NH2 REMARK 470 PHE A1089 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ASP A1101 CG OD1 OD2 REMARK 470 ARG A1148 CD NE CZ NH1 NH2 REMARK 470 GLU A1150 CG CD OE1 OE2 REMARK 470 LYS A1244 CG CD CE NZ REMARK 470 ASP A1286 CG OD1 OD2 REMARK 470 ASN A1288 CG OD1 ND2 REMARK 470 GLU A1314 CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A1113 -113.20 -77.63 REMARK 500 ASN A1175 72.31 22.38 REMARK 500 ARG A1203 -16.27 78.43 REMARK 500 ASP A1204 48.59 -146.43 REMARK 500 TYR A1307 -11.23 76.74 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE L1X A 1401 DBREF 4EEV A 1038 1346 UNP P08581 MET_HUMAN 1038 1346 SEQADV 4EEV MET A 1030 UNP P08581 INITIATING METHIONINE SEQADV 4EEV HIS A 1031 UNP P08581 EXPRESSION TAG SEQADV 4EEV HIS A 1032 UNP P08581 EXPRESSION TAG SEQADV 4EEV HIS A 1033 UNP P08581 EXPRESSION TAG SEQADV 4EEV HIS A 1034 UNP P08581 EXPRESSION TAG SEQADV 4EEV HIS A 1035 UNP P08581 EXPRESSION TAG SEQADV 4EEV HIS A 1036 UNP P08581 EXPRESSION TAG SEQADV 4EEV MET A 1037 UNP P08581 EXPRESSION TAG SEQRES 1 A 317 MET HIS HIS HIS HIS HIS HIS MET GLY ASP SER ASP ILE SEQRES 2 A 317 SER SER PRO LEU LEU GLN ASN THR VAL HIS ILE ASP LEU SEQRES 3 A 317 SER ALA LEU ASN PRO GLU LEU VAL GLN ALA VAL GLN HIS SEQRES 4 A 317 VAL VAL ILE GLY PRO SER SER LEU ILE VAL HIS PHE ASN SEQRES 5 A 317 GLU VAL ILE GLY ARG GLY HIS PHE GLY CYS VAL TYR HIS SEQRES 6 A 317 GLY THR LEU LEU ASP ASN ASP GLY LYS LYS ILE HIS CYS SEQRES 7 A 317 ALA VAL LYS SER LEU ASN ARG ILE THR ASP ILE GLY GLU SEQRES 8 A 317 VAL SER GLN PHE LEU THR GLU GLY ILE ILE MET LYS ASP SEQRES 9 A 317 PHE SER HIS PRO ASN VAL LEU SER LEU LEU GLY ILE CYS SEQRES 10 A 317 LEU ARG SER GLU GLY SER PRO LEU VAL VAL LEU PRO TYR SEQRES 11 A 317 MET LYS HIS GLY ASP LEU ARG ASN PHE ILE ARG ASN GLU SEQRES 12 A 317 THR HIS ASN PRO THR VAL LYS ASP LEU ILE GLY PHE GLY SEQRES 13 A 317 LEU GLN VAL ALA LYS GLY MET LYS TYR LEU ALA SER LYS SEQRES 14 A 317 LYS PHE VAL HIS ARG ASP LEU ALA ALA ARG ASN CYS MET SEQRES 15 A 317 LEU ASP GLU LYS PHE THR VAL LYS VAL ALA ASP PHE GLY SEQRES 16 A 317 LEU ALA ARG ASP MET TYR ASP LYS GLU TYR TYR SER VAL SEQRES 17 A 317 HIS ASN LYS THR GLY ALA LYS LEU PRO VAL LYS TRP MET SEQRES 18 A 317 ALA LEU GLU SER LEU GLN THR GLN LYS PHE THR THR LYS SEQRES 19 A 317 SER ASP VAL TRP SER PHE GLY VAL LEU LEU TRP GLU LEU SEQRES 20 A 317 MET THR ARG GLY ALA PRO PRO TYR PRO ASP VAL ASN THR SEQRES 21 A 317 PHE ASP ILE THR VAL TYR LEU LEU GLN GLY ARG ARG LEU SEQRES 22 A 317 LEU GLN PRO GLU TYR CYS PRO ASP PRO LEU TYR GLU VAL SEQRES 23 A 317 MET LEU LYS CYS TRP HIS PRO LYS ALA GLU MET ARG PRO SEQRES 24 A 317 SER PHE SER GLU LEU VAL SER ARG ILE SER ALA ILE PHE SEQRES 25 A 317 SER THR PHE ILE GLY HET L1X A1401 41 HETNAM L1X N-(3-FLUORO-4-{[1-METHYL-6-(1H-PYRAZOL-4-YL)-1H- HETNAM 2 L1X INDAZOL-5-YL]OXY}PHENYL)-1-(4-FLUOROPHENYL)-6-METHYL- HETNAM 3 L1X 2-OXO-1,2-DIHYDROPYRIDINE-3-CARBOXAMIDE FORMUL 2 L1X C30 H22 F2 N6 O3 FORMUL 3 HOH *125(H2 O) HELIX 1 1 LEU A 1047 VAL A 1051 5 5 HELIX 2 2 ASP A 1054 LEU A 1058 5 5 HELIX 3 3 ASN A 1059 VAL A 1069 1 11 HELIX 4 4 GLY A 1072 SER A 1074 5 3 HELIX 5 5 ASP A 1117 ASP A 1133 1 17 HELIX 6 6 ASP A 1164 ASN A 1171 1 8 HELIX 7 7 THR A 1177 LYS A 1198 1 22 HELIX 8 8 ALA A 1206 ARG A 1208 5 3 HELIX 9 9 PRO A 1246 MET A 1250 5 5 HELIX 10 10 ALA A 1251 GLN A 1258 1 8 HELIX 11 11 THR A 1261 THR A 1278 1 18 HELIX 12 12 ASP A 1291 GLN A 1298 1 8 HELIX 13 13 PRO A 1309 TRP A 1320 1 12 HELIX 14 14 LYS A 1323 ARG A 1327 5 5 HELIX 15 15 SER A 1329 PHE A 1344 1 16 SHEET 1 A 5 LEU A1076 ARG A1086 0 SHEET 2 A 5 GLY A1090 LEU A1098 -1 O VAL A1092 N ILE A1084 SHEET 3 A 5 LYS A1104 LEU A1112 -1 O VAL A1109 N TYR A1093 SHEET 4 A 5 LEU A1154 PRO A1158 -1 O VAL A1155 N LYS A1110 SHEET 5 A 5 GLY A1144 CYS A1146 -1 N GLY A1144 O VAL A1156 SHEET 1 B 2 CYS A1210 LEU A1212 0 SHEET 2 B 2 VAL A1218 VAL A1220 -1 O LYS A1219 N MET A1211 SITE 1 AC1 17 ILE A1084 VAL A1092 ALA A1108 LYS A1110 SITE 2 AC1 17 GLU A1127 ILE A1130 MET A1131 LEU A1157 SITE 3 AC1 17 PRO A1158 TYR A1159 MET A1160 LEU A1195 SITE 4 AC1 17 VAL A1220 ALA A1221 ASP A1222 PHE A1223 SITE 5 AC1 17 HOH A1618 CRYST1 40.508 63.886 111.631 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024686 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015653 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008958 0.00000